Publication Name	World Journal of Clinical Cases
Manuscript ID	98084
Country	China

Received	2024-06-18 13:17
Peer-Review Started	2024-06-18 13:17
To Make the First Decision
Return for Revision	2024-10-11 04:21
Revised	2024-10-12 07:51
Second Decision	2024-11-07 02:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-07 10:01
Articles in Press	2024-11-07 10:01
Publication Fee Transferred	2024-10-21 06:11
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-18 01:21
Publish the Manuscript Online	2024-11-25 09:10

ISSN	2307-8960 (online)
Open Access	Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Anlotinib-induced sick sinus syndrome: Two case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Cheng-Feng Fu, Li-Fen Yang, Lei Tian, Song Deng, Qi Zhang and Biao Yao
ORCID	Author(s) ORCID Number Cheng-Feng Fu http://orcid.org/0000-0001-6724-8922 Qi Zhang http://orcid.org/0009-0002-7700-8812
Funding Agency and Grant Number
Corresponding Author	Qi Zhang, Associate Chief Physician, PhD, Department of Oncology, Guizhou Provincial People’s Hospital, No. 83 Zhongshan East Road, Nanming District, Guiyang 550000, Guizhou Province, China. kekexinqing@163.com
Key Words	Lung cancer; Anlotinib; Sick sinus syndrome; Cardiac pacemaker; Adverse drug reaction; Case report
Core Tip	This case report presents the first known instances of sick sinus syndrome associated with the use of anlotinib in patients with non-small cell lung cancer, emphasizing the importance of cardiac monitoring during treatment. The report compares two different management approaches for anlotinib-induced sick sinus syndrome, one with a dual-chamber permanent pacemaker and the other with medication discontinuation, providing valuable insights for clinical practice.
Publish Date	2024-11-25 09:10
Citation	<p>Fu CF, Yang LF, Tian L, Deng S, Zhang Q, Yao B. Anlotinib-induced sick sinus syndrome: Two case reports. <i>World J Clin Cases</i> 2025; 13(6): 98084</p>
URL	https://www.wjgnet.com/2307-8960/full/v13/i6/98084.htm
DOI	https://dx.doi.org/10.12998/wjcc.v13.i6.98084

Full Article (PDF)	WJCC-13-98084-with-cover.pdf
CARE Checklist–2016	98084-CARE-Checklist-2016.pdf
Manuscript File	98084_Auto_Edited_063021.docx
Answering Reviewers	98084-answering-reviewers.pdf
Audio Core Tip	98084-audio.m4a
Conflict-of-Interest Disclosure Form	98084-conflict-of-interest-statement.pdf
Copyright License Agreement	98084-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	98084-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	98084-non-native-speakers.pdf
Peer-review Report	98084-peer-reviews.pdf
Scientific Misconduct Check	98084-scientific-misconduct-check.png
Scientific Editor Work List	98084-scientific-editor-work-list.pdf
CrossCheck Report	98084-crosscheck-report.pdf